comparemela.com
Home
Live Updates
Dissecting Exciting Opportunities - Breaking News
Pages:
Latest Breaking News On - Dissecting exciting opportunities - Page 1 : comparemela.com
NeuroSense Therapeutics to Present at the ALS Drug Development Summit in Boston on May 26, 2022
/PRNewswire/ NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today.
United states
United kingdom
City of
Ferenc tracik
Nedira salzman frenkel
Shiran zimri
Company head of scientific program
Prnewswire neurosense therapeutics ltd
Drug development summit
Neurosense therapeutics ltd
European network to cure
European medicines agency
Business development
Combination therapy
Target complexity
Sense therapeutics
vimarsana © 2020. All Rights Reserved.